Q3 EPS Estimates for Organigram Increased by Analyst

Organigram Holdings Inc. (NASDAQ:OGI - Free Report) - Investment analysts at Alliance Global Partners lifted their Q3 2025 earnings estimates for shares of Organigram in a research note issued on Tuesday, February 11th. Alliance Global Partners analyst A. Grey now forecasts that the company will earn ($0.02) per share for the quarter, up from their previous estimate of ($0.03). The consensus estimate for Organigram's current full-year earnings is ($0.09) per share. Alliance Global Partners also issued estimates for Organigram's Q4 2025 earnings at ($0.02) EPS, FY2025 earnings at ($0.18) EPS and FY2026 earnings at ($0.06) EPS.

Organigram Trading Up 7.1 %

Shares of OGI traded up $0.09 during mid-day trading on Friday, hitting $1.36. The company's stock had a trading volume of 1,705,294 shares, compared to its average volume of 914,274. Organigram has a 52-week low of $1.27 and a 52-week high of $2.91. The company's 50-day moving average is $1.55 and its 200-day moving average is $1.66. The firm has a market capitalization of $171.58 million, a price-to-earnings ratio of -3.58 and a beta of 1.00.

Organigram (NASDAQ:OGI - Get Free Report) last announced its quarterly earnings results on Tuesday, February 11th. The company reported ($0.05) earnings per share for the quarter, missing the consensus estimate of ($0.03) by ($0.02). Organigram had a negative return on equity of 11.68% and a negative net margin of 28.58%.

Institutional Investors Weigh In On Organigram

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Clear Harbor Asset Management LLC lifted its position in Organigram by 37.4% during the fourth quarter. Clear Harbor Asset Management LLC now owns 45,000 shares of the company's stock valued at $72,000 after acquiring an additional 12,250 shares during the last quarter. Toronto Dominion Bank lifted its position in Organigram by 803.7% during the third quarter. Toronto Dominion Bank now owns 16,727 shares of the company's stock valued at $30,000 after acquiring an additional 14,876 shares during the last quarter. Two Sigma Securities LLC purchased a new stake in Organigram during the fourth quarter valued at approximately $26,000. Renaissance Technologies LLC lifted its position in Organigram by 2.4% during the fourth quarter. Renaissance Technologies LLC now owns 914,648 shares of the company's stock valued at $1,473,000 after acquiring an additional 21,200 shares during the last quarter. Finally, Cubist Systematic Strategies LLC lifted its position in Organigram by 210.7% during the fourth quarter. Cubist Systematic Strategies LLC now owns 45,095 shares of the company's stock valued at $73,000 after acquiring an additional 30,583 shares during the last quarter. Hedge funds and other institutional investors own 34.63% of the company's stock.

Organigram Company Profile

Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.